Antibe Therapeutics Inc (ATE.TO)
0.295
0.00 (0.00%)
CAD |
TSX |
Apr 25, 16:00
Antibe Therapeutics Total Assets (Quarterly): 56.36M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 56.36M |
| September 30, 2023 | 60.20M |
| June 30, 2023 | 66.84M |
| March 31, 2023 | 70.56M |
| December 31, 2022 | 73.73M |
| September 30, 2022 | 79.17M |
| June 30, 2022 | 83.49M |
| March 31, 2022 | 89.16M |
| December 31, 2021 | 92.47M |
| September 30, 2021 | 95.86M |
| June 30, 2021 | 102.86M |
| March 31, 2021 | 81.74M |
| December 31, 2020 | 24.52M |
| September 30, 2020 | 29.74M |
| June 30, 2020 | 38.83M |
| March 31, 2020 | 13.84M |
| December 31, 2019 | 15.22M |
| September 30, 2019 | 17.41M |
| June 30, 2019 | 12.89M |
| March 31, 2019 | 14.82M |
| December 31, 2018 | 12.26M |
| September 30, 2018 | 12.12M |
| Date | Value |
|---|---|
| June 30, 2018 | 13.02M |
| March 31, 2018 | 12.49M |
| December 31, 2017 | 10.34M |
| September 30, 2017 | 12.02M |
| June 30, 2017 | 12.97M |
| March 31, 2017 | 10.73M |
| December 31, 2016 | 11.09M |
| September 30, 2016 | 9.807M |
| June 30, 2016 | 10.61M |
| March 31, 2016 | 9.740M |
| December 31, 2015 | 9.928M |
| September 30, 2015 | 0.8599M |
| June 30, 2015 | 1.539M |
| March 31, 2015 | 0.7893M |
| December 31, 2014 | 1.242M |
| September 30, 2014 | 2.417M |
| June 30, 2014 | 3.419M |
| March 31, 2014 | 4.352M |
| December 31, 2013 | 1.983M |
| September 30, 2013 | 1.838M |
| June 30, 2013 | 2.036M |
| March 31, 2013 | 0.738M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.89M
Minimum
Jun 2019
102.86M
Maximum
Jun 2021
58.15M
Average
66.84M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Biocure Technology Inc | 3.496M |
| Core One Labs Inc | 7.400M |
| Nova Mentis Life Science Corp | 0.0539M |
| Nanosphere Health Sciences Inc | 0.0258M |
| Lobe Sciences Ltd | 2.190M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.42M |
| Shareholders Equity (Quarterly) | 25.94M |